Harvard Bioscience (HBIO) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $3.97 -2.93%
EPS Growth %: -16.7%
Financial Fact:
Basic earnings per common share: -0.05
Today's EPS Names:
ESCA, LICT, NKSH, More
EPS Growth %: -16.7%
Financial Fact:
Basic earnings per common share: -0.05
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.05, $0.03 better than the analyst estimate of $0.02. Revenue for the quarter came in at $27 million versus the consensus estimate of $26 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Southern First Bancshares, Inc. (SFST) Misses Q1 EPS by 8c
- Intuitive Surgiical (ISRG) beats earnings, revenue expectations in Q1
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
